This study is a non-drug, multicenter, prospective cohort study. It will be conducted in 300 volunteers from 12 to 45 years of age (inclusive) with a diagnosis of Down syndrome from 3 countries (France, Spain, United Kingdom (UK)). The basic hypotheses of the study are the following: 1. Diseases (and comorbidity) arise from one or more biological networks perturbed by the genetic disorder (trisomy 21) through interaction with environmental risks factors and epigenetic changes. 2. Health comorbidity patterns in DS individuals (particularly of obesity and related conditions) will likely vary by age and sex. 3. Obesity comorbidity patterns will relate to variation in factors including lifestyle, stress-response, severity of intellectual disability (ID) and variation in cognitive domains such as executive functioning. 4. Stress responses, as measured with cortisol concentrations, will differentiate individuals with DS who are obese and those who are not. Extremes in phenotype (Obese vs. Non-obese) will be related to differences in the metabolomic, transcriptomic, and microbiome concentrations.
The study will be conducted in n= 300 volunteers with DS from 3 countries (France, Spain, UK); equal numbers in 3 age groups (12 - 18 years; 19 - 34 years; 35 - 45 years). The total number of volunteers expected to be included in each country is n = 100. From the initial cross-sectional cohort, individuals will be selected on the basis of obesity status and invited to participate in a nested case-control study (n = 30 for normal weight DS individuals and n = 30 DS individuals with extreme phenotype). In adults, normal weight is defined as BMI 18.5 to 24.9 and significant obesity as BMI \> 35 kg/m2. In children under age 18, the research team will use the International Obesity Task Force (IOTF) curves which are international norms) with IOTF \> 30 for obese and IOTF 18.5 - 25 for the normal weight group. The research team will monitor allocation using monthly eCRF recruitment reports for central allocation of recruits to ensure balance between age, sex and BMI between the "cases" and the "controls".
Study Type
OBSERVATIONAL
Enrollment
230
No interventions - observational study
Institute Jérôme Lejeune
Paris, France
Institut Hospital del Mar d'Investigacions Mèdiques
Barcelona, Spain
King's College London
London, United Kingdom
Body Mass Index
Height and weight measurements will be aggregated to arrive at one reported value: Body Mass Index (BMI), in kg/m\^2
Time frame: 1 year
Food Frequency Questionnaire
Average daily nutrient intake
Time frame: 1 year
Short Minnesota Leisure Time Physical Activity Questionnaire
Energy expenditure in 14 days
Time frame: 1 year
Mental health questionnaire
Reiss Screen for Maladaptive Behaviour - composite outcome measure consisting of the following multiple sub-measures: * Aggressive behavior * Autism * Psychosis * Paranoia * Depression (behavioural signs) * Depression (physical signs) * Dependent personality disorder * Avoidant disorder
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.